Adverse drug reaction

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase I/II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase I/II

1 trial
  • Medical Center - University Of Freiburg Academic
    METHOXSALEN
    2024-513614-36-00 1 country 2022 n=30
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Medical Center - University Of Freiburg Academic 1 Phase I/II 0
New trials by year
2022
1
← All indication landscapes